Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study

No standard chemotherapy is available after disease progression or anaphylaxis during platinum chemotherapy among patients with recurrent cervical cancer. Here we report the efficacy and toxicities of metronomic chemotherapy consisting of 50 mg of oral cyclophosphamide (CPA) daily and intravenous 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Isono-Taniguchi, Roze, Goto, Mayako, Takimoto, Yumi, Ueda, Tomoko, Wakimoto, Yu, Inoue, Kayo, Hori, Kensuke, Ito, Kimihiko, Tsubamoto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475695/
https://www.ncbi.nlm.nih.gov/pubmed/36118995
http://dx.doi.org/10.1016/j.gore.2022.101013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475695/
https://www.ncbi.nlm.nih.gov/pubmed/36118995
http://dx.doi.org/10.1016/j.gore.2022.101013

Ejemplares similares